Accuracy of rapid blood coagulation testing device FibCare® in a tertiary emergency department

Aim FibCare® is a novel point‐of‐care testing device enabling prompt evaluation of fibrinogen levels. This study aimed to investigate the accuracy of FibCare® at a tertiary emergency department. Methods Blood specimens obtained at a tertiary emergency medical center between October 1, 2021, and Apri...

Full description

Saved in:
Bibliographic Details
Published in:Acute medicine & surgery 2024-01, Vol.11 (1), p.e934-n/a
Main Authors: Mihara, Yutaka, Komoriya, Kenta, Hagiwara, Kei, Hatanaka, Yasuhito, Shibahashi, Keita, Hikone, Mayu, Sugiyama, Kazuhiro
Format: Article
Language:English
Subjects:
Accuracy
blood coagulation
diagnosis
Emergency medical care
emergency room
fibrinogen
Hemorrhage
Molecular weight
Original
Patients
Plasma
Postpartum period
trauma
Viscoelasticity
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aim FibCare® is a novel point‐of‐care testing device enabling prompt evaluation of fibrinogen levels. This study aimed to investigate the accuracy of FibCare® at a tertiary emergency department. Methods Blood specimens obtained at a tertiary emergency medical center between October 1, 2021, and April 30, 2023, were evaluated. The correlation between the fibrinogen levels assessed via FibCare® and those via the Clauss method was evaluated using the Spearman's test. The discrepancy between the two measurement methods was assessed according to fibrinogen level and diagnosis. Results A total of 177 specimens from 147 patients were eligible for the analysis. The median age of the patients was 49 years, and 109 (61.6%) were men. The two measurements had statistically significant but moderate correlation (p 
ISSN:2052-8817
2052-8817
DOI:10.1002/ams2.934